TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)

TELA Bio's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$298000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 156.9% year-over-year to -$298000.0; the TTM figure through Mar 2026 stood at $25.6 million (down 40.38% YoY), while the FY2025 annual figure was $25.8 million, down 40.2% from the prior year.
• Cash from Financing Activities was -$298000.0 for Q1 2026 at TELA Bio, down from $25.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $46.4 million in Q2 2023 to a low of -$298000.0 in Q1 2026.
• Historically, Cash from Financing Activities has averaged $9.2 million across 5 years, with a median of $24000.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities slumped 505.56% in 2022, then surged 194936.36% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$219000.0 in 2022, then surged by 110.05% to $22000.0 in 2023, then soared by 194936.36% to $42.9 million in 2024, then sank by 39.77% to $25.8 million in 2025, then sank by 101.15% to -$298000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$298000.0 (Q1 2026), $25.8 million (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.